水合作用与肾脏健康。 - Suppr

Suppr

超能文献

Hydration and kidney health.

作者信息

Bouby Nadine, Clark William F, Roussel Ronan, Taveau Christopher, Wang Connie J

机构信息

INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.

出版信息

Obes Facts. 2014;7 Suppl 2(Suppl 2):19-32. doi: 10.1159/000360889. Epub 2014 Apr 4.

DOI:10.1159/000360889

PMID:24853348

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5646211/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc1/5646211/ecaa9a07e0c0/ofa-0007-0019-g01.jpg

相似文献

Hydration and kidney health.

Obes Facts. 2014;7 Suppl 2(Suppl 2):19-32. doi: 10.1159/000360889. Epub 2014 Apr 4.

Effects of acute and chronic hypohydration on kidney health and function.

Nutr Rev. 2015 Sep;73 Suppl 2:110-9. doi: 10.1093/nutrit/nuv046.

Could the pattern of water consumption alter its potential medicinal effects?

Kidney Int. 2014 Feb;85(2):478. doi: 10.1038/ki.2013.428.

Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats.

J Appl Toxicol. 2008 Apr;28(3):388-98. doi: 10.1002/jat.1292.

Biology of the kidney in health and disease--a new series.

Hosp Pract. 1978 May;13(5):11, 17. doi: 10.1080/21548331.1978.11707327.

Disorders of water and electrolyte metabolism in liver disease.

Am J Clin Nutr. 1970 Apr;23(4):499-507. doi: 10.1093/ajcn/23.4.499.

Waterlogged?

BMJ. 2011 Jul 12;343:d4280. doi: 10.1136/bmj.d4280.

Doctor, how much should I drink?

Nefrologia. 2014 Nov 17;34(6):693-7. doi: 10.3265/Nefrologia.pre2014.Jul.12610.

Hydration for Health Conference Emphasizes Vasopressin and Kidney Diseases.

Ann Nutr Metab. 2018;72 Suppl 2:1-2. doi: 10.1159/000488122. Epub 2018 Jun 19.

[Rational electrolyte therapy].

Wien Klin Wochenschr. 1959 May 15;71(20):354-6.

引用本文的文献

Reference Values for Hydration Biomarkers: Optimizing Athletic Performance and Recovery.

Open Access J Sports Med. 2025 Apr 7;16:31-50. doi: 10.2147/OAJSM.S508656. eCollection 2025.

Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation.

World J Nephrol. 2025 Mar 25;14(1):101515. doi: 10.5527/wjn.v14.i1.101515.

Water Intake, Water Balance, and the Elusive Daily Water Requirement.

Nutrients. 2018 Dec 5;10(12):1928. doi: 10.3390/nu10121928.

H4H - hydration for health.

Obes Facts. 2014;7 Suppl 2(Suppl 2):1-5. doi: 10.1159/000360666. Epub 2014 Apr 4.

本文引用的文献

The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trial.

BMJ Open. 2013 Dec 20;3(12):e003666. doi: 10.1136/bmjopen-2013-003666.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9.

Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.

Diabetes Care. 2013 Nov;36(11):3639-45. doi: 10.2337/dc13-0683. Epub 2013 Jul 17.

Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).

Diabetologia. 2013 Aug;56(8):1680-8. doi: 10.1007/s00125-013-2922-0. Epub 2013 Apr 28.

Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data.

Am J Nephrol. 2013;37(5):434-42. doi: 10.1159/000350377. Epub 2013 Apr 17.

Vasopressin: a novel target for the prevention and retardation of kidney disease?

Nat Rev Nephrol. 2013 Apr;9(4):223-39. doi: 10.1038/nrneph.2013.22. Epub 2013 Feb 26.

Tolvaptan in patients with autosomal dominant polycystic kidney disease.

N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3.

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.

Int J Obes (Lond). 2013 Apr;37(4):598-603. doi: 10.1038/ijo.2012.88. Epub 2012 May 22.

CKD in Central America: a hot issue.

Am J Kidney Dis. 2012 Apr;59(4):481-4. doi: 10.1053/j.ajkd.2012.01.005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hydration and kidney health.

Obes Facts. 2014;7 Suppl 2(Suppl 2):19-32. doi: 10.1159/000360889. Epub 2014 Apr 4.

Effects of acute and chronic hypohydration on kidney health and function.

Nutr Rev. 2015 Sep;73 Suppl 2:110-9. doi: 10.1093/nutrit/nuv046.

Could the pattern of water consumption alter its potential medicinal effects?

Kidney Int. 2014 Feb;85(2):478. doi: 10.1038/ki.2013.428.

Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats.

J Appl Toxicol. 2008 Apr;28(3):388-98. doi: 10.1002/jat.1292.

Biology of the kidney in health and disease--a new series.

Hosp Pract. 1978 May;13(5):11, 17. doi: 10.1080/21548331.1978.11707327.

Disorders of water and electrolyte metabolism in liver disease.

Am J Clin Nutr. 1970 Apr;23(4):499-507. doi: 10.1093/ajcn/23.4.499.

Waterlogged?

BMJ. 2011 Jul 12;343:d4280. doi: 10.1136/bmj.d4280.

Doctor, how much should I drink?

Nefrologia. 2014 Nov 17;34(6):693-7. doi: 10.3265/Nefrologia.pre2014.Jul.12610.

Hydration for Health Conference Emphasizes Vasopressin and Kidney Diseases.

Ann Nutr Metab. 2018;72 Suppl 2:1-2. doi: 10.1159/000488122. Epub 2018 Jun 19.

[Rational electrolyte therapy].

Wien Klin Wochenschr. 1959 May 15;71(20):354-6.

引用本文的文献

Reference Values for Hydration Biomarkers: Optimizing Athletic Performance and Recovery.

Open Access J Sports Med. 2025 Apr 7;16:31-50. doi: 10.2147/OAJSM.S508656. eCollection 2025.

Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation.

World J Nephrol. 2025 Mar 25;14(1):101515. doi: 10.5527/wjn.v14.i1.101515.

Water Intake, Water Balance, and the Elusive Daily Water Requirement.

Nutrients. 2018 Dec 5;10(12):1928. doi: 10.3390/nu10121928.

H4H - hydration for health.

Obes Facts. 2014;7 Suppl 2(Suppl 2):1-5. doi: 10.1159/000360666. Epub 2014 Apr 4.

本文引用的文献

The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trial.

BMJ Open. 2013 Dec 20;3(12):e003666. doi: 10.1136/bmjopen-2013-003666.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9.

Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.

Diabetes Care. 2013 Nov;36(11):3639-45. doi: 10.2337/dc13-0683. Epub 2013 Jul 17.

Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).

Diabetologia. 2013 Aug;56(8):1680-8. doi: 10.1007/s00125-013-2922-0. Epub 2013 Apr 28.

Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data.

Am J Nephrol. 2013;37(5):434-42. doi: 10.1159/000350377. Epub 2013 Apr 17.

Vasopressin: a novel target for the prevention and retardation of kidney disease?

Nat Rev Nephrol. 2013 Apr;9(4):223-39. doi: 10.1038/nrneph.2013.22. Epub 2013 Feb 26.

Tolvaptan in patients with autosomal dominant polycystic kidney disease.

N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3.

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.

Int J Obes (Lond). 2013 Apr;37(4):598-603. doi: 10.1038/ijo.2012.88. Epub 2012 May 22.

CKD in Central America: a hot issue.

Am J Kidney Dis. 2012 Apr;59(4):481-4. doi: 10.1053/j.ajkd.2012.01.005.